CITATIONS

1.   Gaul LE, Staud AH: Seventy cases of generalized argyria following organic and colloidal silver medication, including biospectrometric analysis of ten cases.
AMA 104:1387-1390,1935.

2.   Stillians AW: Argyria. Arch Dermatol 35:67-77,1937.

3.   Bryant BL: Argyria resulting from intranasal medication. Arch Otolaryngol
31:127-139,1940.

4.   Gaul LE, Staud AH: Seventy cases of generalized argyria following organic and colloidal silver medication, including biospectrometric analysis of ten cases.
AMA 104:1387-1390,1935, p.1387.

5.   Bryant BL: Argyria resulting from intranasal medication. Arch Otolaryngol
31:127-139, 1940, p. 136 & 137.

6.   Bryant BL: Argyria resulting from intranasal medication. Arch Otolaryngol
31:127-139, 1940, p. 138.

7.   Levine SA, Smith JA: Argyria confused with heart disease. N Eng I Med
226:682-684,1942, p. 682.

8.   Marshall CR, Killoh GB: The Bactericidal Action of Collosols of Silver & Mecury
British Med 1. Jan. 16, 1915, p. 102.

9.   Collosols - British Colloids Limited, JAMA 78:674-675, March 4, 1922. p. 674.

10.  Marshall CR, Killoh GB: The Bactericidal Action of Coflosols of Silver & Mecury
British Med J. Jan. 16, 1915, p. 102.

11.  Collosols - British Colloids Limited, JAMA 78:674-675, March 4, 1922. p. 675.

12.  Puckner WA: Collosol preparations Report of the Council on Pharmacy and Chemistry. JAMA June 7, 1919, p. 1694.

13.  Puckner WA: Coflosol preparations Report of the Council on Pharmacy and Chemistry. JAMA June 7, 1919, p. 1694.

14.  Roe AL, Collosol argentum and its ophthalmic uses. British Med J. Jan. 16, 1915, p. 104.

15.  Hartman Rj: Colloid Chemistry lst edition, Baltimore, Nhfflin, 1939, p. 536.

16.  Hill VVR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939.

17.  Hill WR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939, p. 85.

18.  Hill VVR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939, p.132.

19.  Hill WR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939, p.132.

20.  Hill WR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939, p.131.

21.  Hill WR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939, p.128.

22.  Goodman LS, Gihnan A: The Pharmacological Basis of Therapeutics. 5th edition. New York: MacMillan, 1975:930-931, 999-1000.

23.  Hill WR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md.  Williams & Wilkins Co, 1939, p. 26 & 95.

24.  Hill WR, Pillsbury DM: Argyria: The Pharmacology of Silver, Baltimore, Md. Williams & Wilkins Co, 1939, p. 131.

25.  Bryant BL: Argyria resulting from intranasal medication. Arch Otolaryngol
31:127-139,1940, p. 138. 26.  Harker JM, Hunter D: Occupational Argyria British j Derm & Syph Nov. 1935 p.442,445,446.

27.  Gaul LE, Staud AH: Seventy cases of generalized argyria following organic and colloidal silver medication, including biospectrometric analysis of ten cases.
AMA 104:1387-1390,1935, p. 1389.

28.  Fung MC, Bowen DL: Silver Products for Medicinal Indications: Risk - Benefit Assessment Clinical Toxicology, 34(l), 119-126(1996), p. 120.